484 related articles for article (PubMed ID: 15481288)
1. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
2. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS
Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
[TBL] [Abstract][Full Text] [Related]
3. An aggressive approach to extrahepatic cholangiocarcinomas is warranted: margin status does not impact survival after resection.
Hernandez J; Cowgill SM; Al-Saadi S; Villadolid D; Ross S; Kraemer E; Shapiro M; Mullinax J; Cooper J; Goldin S; Zervos E; Rosemurgy A
Ann Surg Oncol; 2008 Mar; 15(3):807-14. PubMed ID: 18181000
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
5. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
7. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.
Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S
Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438
[TBL] [Abstract][Full Text] [Related]
8. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
9. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
10. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
11. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
Konstadoulakis MM; Roayaie S; Gomatos IP; Labow D; Fiel MI; Miller CM; Schwartz ME
Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
Endo I; House MG; Klimstra DS; Gönen M; D'Angelica M; Dematteo RP; Fong Y; Blumgart LH; Jarnagin WR
Ann Surg Oncol; 2008 Aug; 15(8):2104-12. PubMed ID: 18543039
[TBL] [Abstract][Full Text] [Related]
13. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
14. Our experiences in surgical treatment for hilar cholangiocarcinoma.
Maeno H; Ono T; Yamanoi A; Nagasue N
Hepatogastroenterology; 2007; 54(75):669-73. PubMed ID: 17591038
[TBL] [Abstract][Full Text] [Related]
15. In-continuity hepatic resection for advanced hilar cholangiocarcinoma.
Zervos EE; Pearson H; Durkin AJ; Thometz D; Rosemurgy P; Kelley S; Rosemurgy AS
Am J Surg; 2004 Nov; 188(5):584-8. PubMed ID: 15546575
[TBL] [Abstract][Full Text] [Related]
16. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
Miyazaki M; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Nozawa S
Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
[TBL] [Abstract][Full Text] [Related]
17. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
[TBL] [Abstract][Full Text] [Related]
18. [An analysis on prognostic factors of hilar cholangiocarcinoma].
Zhou LX; Zhang ZW; Xu ZY
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
[TBL] [Abstract][Full Text] [Related]
19. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]